In line with these findings, Zhang et al. (2015) found that the DPP4 inhibitor linagliptin lowered the expression of the AT1R and upregulated the activity of ACE2 in the heart in rats with Ang II-induced hypertension. This evidence concerns the gene DPP4 and Hypertension.